QuidelOrtho Corporation, a major player in in vitro diagnostics, has announced the appointment of Erich Wolff as Executive Vice President of Strategy and Corporate Development. In this role, Mr. Wolff will report directly to President and CEO Brian Blaser. His responsibilities will include shaping the company’s overall strategy, leading business development, handling government affairs, and managing initiatives focused on growing the company’s portfolio.
Health Technology Insights: Manipal Hospitals Welcomes Dr. Surender Kumar Dabas to Boost Cancer Care
Mr. Wolff has over 20 years of experience in strategic planning, mergers and acquisitions, and business development in the healthcare, diagnostics, and MedTech sectors. Most recently, he worked at Partners Group, a global private equity firm with $174 billion in assets, where he led investments in MedTech and Life Sciences Tools and Diagnostics. Earlier in his career, he held senior positions at BD and Medtronic, where he helped drive corporate growth and transformation through strategic planning, investment execution, and acquisitions. “Mr. Wolff brings a rare combination of strategic vision, operational rigor and transaction expertise,” said Brian Blaser, President and Chief Executive Officer at QuidelOrtho. “His ability to drive complex portfolio decisions and execute high-impact growth strategies will be invaluable as we continue to advance the power of diagnostics for a healthier future.”
Health Technology Insights: MY DR NOW Expands Tucson Presence with New Oracle and Ina Clinic
At Medtronic, Mr. Wolff played a key role in redefining the company’s global diabetes unit and later expanded his focus to include corporate development across both the neurosciences and diabetes divisions, which together generated $11.5 billion in revenue. At BD, he was involved in the spinoff of embecta, led the $1.5 billion acquisition of Parata Systems, and managed the sale of BD’s Surgical Instrumentation business.
“I’m honored to join QuidelOrtho at such a pivotal time,” said Mr. Wolff. “The Company has a compelling vision for the future of diagnostics, a strong global footprint and a culture of innovation. I look forward to working alongside Brian and the leadership team to shape and execute strategies that can accelerate growth and deliver long-term value to our stakeholders.” Mr. Wolff earned a Bachelor of Business Administration degree in Finance and Economics from the University of Wisconsin–Milwaukee.
Health Technology Insights: 6 Canadian Providers Choose Sectra Cloud Imaging Solution
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
